Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: crystal ball
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Yes, I would have to assume so...since we're not talking about ownership of the patents just the split of the revenue they could generate...the PDS agreement could have a clause in it that stipulates the other parties involvement/approval of a sale of either one's 50% of the licensing revenue....at least if it were my agreement there would be such a clause in there.





JMHO

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply